Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of Pliva patents

Patents where

Current Assignee

Name

Pliva

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 7091187 Compounds, compositions and methods for treatment of inflammatory diseases and conditions	Patent 7091187 was granted and assigned to Pliva on August, 2006 by the United States Patent and Trademark Office.		Pliva	United States Patent and Trademark Office	7091187	August 15, 2006
‌ US Patent 6855707 Method for the treatment of lipid and glucose metabolism disorders	Patent 6855707 was granted and assigned to Pliva on February, 2005 by the United States Patent and Trademark Office.		Pliva	United States Patent and Trademark Office	6855707	February 15, 2005
‌ US Patent 10343993 Processes and intermediates for the preparation of Pimavanserin	Patent 10343993 was granted and assigned to Pliva on July, 2019 by the United States Patent and Trademark Office.	Pliva	Pliva	United States Patent and Trademark Office	10343993	July 9, 2019
‌ US Patent 11427533 Crystalline polymorphs of bardoxolone methyl	Patent 11427533 was granted and assigned to Pliva on August, 2022 by the United States Patent and Trademark Office.	Pliva	Pliva	United States Patent and Trademark Office	11427533	August 30, 2022
‌ US Patent 8138349 Pharmaceutically acceptable salt and polymorphic forms of flupirtine maleate	Patent 8138349 was granted and assigned to Pliva on March, 2012 by the United States Patent and Trademark Office.		Pliva	United States Patent and Trademark Office	8138349	March 20, 2012
‌ US Patent 7345048 Heterocyclic compounds and uses thereof as D-alanyl-D-alanine ligase inhibitors	Patent 7345048 was granted and assigned to Pliva on March, 2008 by the United States Patent and Trademark Office.		Pliva	United States Patent and Trademark Office	7345048	March 18, 2008
‌ US Patent 8217021 Polymorphs of eltrombopag and eltrombopag salts and processes for preparation thereof	Patent 8217021 was granted and assigned to Pliva on July, 2012 by the United States Patent and Trademark Office.		Pliva	United States Patent and Trademark Office	8217021	July 10, 2012
‌ US Patent 8372822 Polymorphs of eltrombopag and eltrombopag salts and processes for preparation thereof	Patent 8372822 was granted and assigned to Pliva on February, 2013 by the United States Patent and Trademark Office.		Pliva	United States Patent and Trademark Office	8372822	February 12, 2013
‌ US Patent 7109176 Nonsteroidal anti-inflammatory substances, compositions and methods for their use	Patent 7109176 was granted and assigned to Pliva on September, 2006 by the United States Patent and Trademark Office.		Pliva	United States Patent and Trademark Office	7109176	September 19, 2006
‌ US Patent 10807953 Processes and intermediates for the preparation of Pimavanserin		Pliva	Pliva	United States Patent and Trademark Office	10807953	October 20, 2020
‌ US Patent 7569549 Isostructural pseudopolymorphs of 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin A	Patent 7569549 was granted and assigned to Pliva on August, 2009 by the United States Patent and Trademark Office.		Pliva	United States Patent and Trademark Office	7569549	August 4, 2009
‌ US Patent 7166583 1,3-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof	Patent 7166583 was granted and assigned to Pliva on January, 2007 by the United States Patent and Trademark Office.		Pliva	United States Patent and Trademark Office	7166583	January 23, 2007
‌ US Patent 7572773 Single dose fast dissolving azithromycin	Patent 7572773 was granted and assigned to Pliva on August, 2009 by the United States Patent and Trademark Office.		Pliva	United States Patent and Trademark Office	7572773	August 11, 2009
‌ US Patent 11434225 Salts and solid state forms of plinabulin		Pliva	Pliva	United States Patent and Trademark Office	11434225	September 6, 2022
‌ US Patent 8569371 Crystal forms of O-desmethylvenlafaxine fumarate			Pliva	United States Patent and Trademark Office	8569371	October 29, 2013
‌ US Patent 6852702 9a-N-[N′-(phenylsulfonyl)carbamoyl] derivatives of 9-deoxo-9-dihydro-9a-aza-9a-homoerythromycin A and of 5-O-desosaminyl-9-deoxo-9-dihydro-9a-aza-9a-homoerythronolide A	Patent 6852702 was granted and assigned to Pliva on February, 2005 by the United States Patent and Trademark Office.		Pliva	United States Patent and Trademark Office	6852702	February 8, 2005
‌ US Patent 6936591 Amorphous 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin A, process for preparing the same, and uses thereof	Patent 6936591 was granted and assigned to Pliva on August, 2005 by the United States Patent and Trademark Office.		Pliva	United States Patent and Trademark Office	6936591	August 30, 2005
‌ US Patent 7037928 Compositions of N-(methylethylaminocarbonyl)-4-(-3-methylphenylamino)-3-pyridylsulfonamide and cyclic oligosaccharides	Patent 7037928 was granted and assigned to Pliva on May, 2006 by the United States Patent and Trademark Office.		Pliva	United States Patent and Trademark Office	7037928	May 2, 2006
‌ US Patent 7070802 Pharmaceutical compositions for lipophilic drugs	Patent 7070802 was granted and assigned to Pliva on July, 2006 by the United States Patent and Trademark Office.		Pliva	United States Patent and Trademark Office	7070802	July 4, 2006
‌ US Patent 6872707 Halo derivatives of 9-deoxo-9a-aza-homerythromycin A	Patent 6872707 was granted and assigned to Pliva on March, 2005 by the United States Patent and Trademark Office.		Pliva	United States Patent and Trademark Office	6872707	March 29, 2005
‌ US Patent 6897211 Thienodibenzoazulene compounds as tumor necrosis factor inhibitors	Patent 6897211 was granted and assigned to Pliva on May, 2005 by the United States Patent and Trademark Office.		Pliva	United States Patent and Trademark Office	6897211	May 24, 2005

21 results

0 selected

21 results

0 selected